triciribine phosphate has been researched along with adenosine kinase in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Crabtree, GW; Edwards, NL; Parks, RE; Townsend, LB; Wotring, LL | 1 |
Borysko, KZ; Buthod, JL; Drach, JC; Holland, LE; Porcari, AR; Ptak, RG; Shipman, C; Townsend, LB | 1 |
Drach, JC; Rosania, GR; Shedden, K; Townsend, LB | 1 |
3 other study(ies) available for triciribine phosphate and adenosine kinase
Article | Year |
---|---|
Mechanism of activation of triciribine phosphate (TCN-P) as a prodrug form of TCN.
Topics: Acenaphthenes; Adenosine Kinase; Animals; Antineoplastic Agents; Biotransformation; Cell Division; Cell Line; Cell Survival; Chromatography, High Pressure Liquid; Erythrocytes; Humans; Hydrolysis; Leukemia L1210; Mice; Nucleotides; Ribonucleotides | 1986 |
Phosphorylation of triciribine is necessary for activity against HIV type 1.
Topics: Acenaphthenes; Adenosine Kinase; Anti-HIV Agents; Biotransformation; Enzyme Inhibitors; HIV-1; Humans; Jurkat Cells; Phosphorylation; Ribonucleosides; Ribonucleotides; Tumor Cells, Cultured | 1998 |
A rational approach to personalized anticancer therapy: chemoinformatic analysis reveals mechanistic gene-drug associations.
Topics: Acenaphthenes; Adenosine Kinase; Antineoplastic Agents; Biotransformation; Catalysis; Cell Line, Tumor; Gene Expression Regulation, Neoplastic; Humans; Medical Informatics; Neoplasms; Oligonucleotides; Ribonucleotides | 2003 |